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Background: Recruitment to trials is complex and often protracted; selection bias may compromise generalisability.
In the mental health field (as elsewhere), diverse factors have been described as hindering researcher access to
potential participants and various strategies have been proposed to overcome barriers. However, the extent to
which various influences identified in the literature are operational across mental health settings in England has not
been systematically examined.
Methods: A cross-sectional, online survey of clinical studies officers employed by the Mental Health Research
Network in England to recruit to trials from National Health Service mental health services. The bespoke questionnaire
invited participants to report exposure to specified influences on recruitment, the perceived impact of these on access
to potential participants, and to describe additional positive or negative influences on recruitment. Analysis employed
descriptive statistics, the framework approach and triangulation of data.
Results: Questionnaires were returned by 98 (58%) of 170 clinical studies officers who reported diverse experience.
Data demonstrated a disjunction between policy and practice. While the particulars of trial design and various
marketing and communication strategies could influence recruitment, consensus was that the culture of NHS mental
health services is not conducive to research. Since financial rewards for recruitment paid to Trusts and feedback about
studies seldom reaching frontline services, clinicians were described as distanced from research. Facing continual
service change and demanding clinical workloads, clinicians generally did not prioritise recruitment activities. Incentives
to trial participants had variable impact on access but recruitment could be enhanced by engagement of senior
investigators and integrating referral with routine practice. Comprehensive, robust feasibility studies and reciprocity
between researchers and clinicians were considered crucial to successful recruitment.
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Conclusions: In the mental health context, researcher access to potential trial participants is multiply influenced.
Gatekeeping clinicians are faced with competing priorities and resources constrain research activity. It seems that
environmental adjustment predicated on equitable resource allocation is needed if clinicians in NHS mental health
services are to fully support the conduct of randomised controlled trials. Whilst cultural transformation, requiring
changes in assumptions and values, is complex, our findings suggest that attention to practical matters can support
this and highlight issues requiring careful consideration.
Keywords: Randomised controlled trials, Recruitment, Mental health, Survey, Clinical studies officers, CSOs, Mental
Health Research Network, National Health Service, NHS, EnglandBackground
Archie Cochrane’s claim in 1972 that the importance of
the randomised controlled trial (RCT) could not be exag-
gerated [1] was prophetic. With the rise of evidence-based
approaches which now scaffold health care decision-
making internationally, his view that evidence from trials
was key to a rational health service has become normative.
RCTs are conducted to examine the efficacy and effective-
ness of diverse health technologies in achieving desired
outcomes in diverse populations. Researchers design ele-
gant trials, with due attention to statistical power and
sample definition to facilitate generalizability of evidence.
However, recruitment of the necessary sample, recognised
as the single most important aspect of a successful trial
[2], is often problematic [3,4]. When recruitment is pro-
tracted and/or insufficient to achieve desired power and
samples are restricted to sub-sets of the target population,
the return on large-scale investment in research and the
generalizability of RCT evidence are compromised. Whilst
of concern across health care, our interest is in the mental
health context.
Extant literature indicates that the difficulties related
to recruiting to mental health trials are complex. Bar-
riers to access to potential participants have been located
within target populations [3], trial designs and organisa-
tions [3-5], with the attitudes and knowledge of clinicians
who mediate – or ‘gatekeep’ [6] – access to potential par-
ticipants commonly cited as a key influence [5]. In this
area generic challenges to research are potentially com-
pounded by the perceived ‘vulnerability’ of potential par-
ticipants. As gatekeepers, clinicians may seek to protect
people for whom they provide care from the perceived
burden of research participation and/or an intervention
perceived to be futile for an intractable condition [3,4].
Symptom profiles also influence referral to studies [7] and
sub-groups of the population are commonly underrepre-
sented [8].
An emerging literature describes models, strategies
and activities which can be applied to overcome barriers
and promote recruitment [5,9,10] in various settings.
Limited research conducted to date demonstrates that
some of these, including reduction in the work associatedwith referral to RCTs, provision of research training and
protected research time, show promise [9] but many re-
main untested.
With evidence to date primarily case study based, the
extent to which various influences on recruitment to tri-
als are operational in National Health Service (NHS)
mental health settings is unknown. There has also been
no systematic examination of the use and effectiveness
of recruitment-promoting strategies. The absence of
such information hinders development of a strategic ap-
proach to optimising recruitment to RCTs in mental
health, undermining achievement of the governments’
commitment to making the NHS a research oriented, in-
novative organization [11]. With a view to supporting
development of study design and recruitment strategies
pertinent to the mental health context, we aimed to ad-
dress this knowledge gap.
Method
To achieve this aim we conducted a cross-sectional, on-
line survey of researchers employed to recruit trial par-
ticipants from NHS mental health services. Specifically
in relation to researcher access to potential participants
in NHS mental health services, our objectives were to
describe:
i. To describe the extent to which influences on
recruitment identified in the literature were
encountered
ii. To describe the perceived impact of these factors on
recruitment; and
iii. To identify additional factors perceived to influence
recruitment.
A favorable ethical opinion was obtained from the
North East UK Research Ethics Committee (reference
number: 12/NE/0104) before data collection commenced.
Materials
Survey instrument
The bespoke questionnaire was iteratively developed by
the authors to address the study objectives. We began by
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systematic but extensive review of the literature and the
authors’ experiences as researchers. This questionnaire
asked respondents to report exposure to factors reported
to promote or hinder recruitment and rate the impact
on access using a seven point scale - strongly negative to
strongly positive. This draft was piloted with a conveni-
ence sample of 28 research assistants recruited from
amongst participants in an in-service training day spon-
sored by the UK Mental Health Research Network
(MHRN; see below). Pilot data and discussion with par-
ticipants supported restructure of the questionnaire
(specifically separation of reporting of exposure and im-
pact and rescaling responses). The revision was trialled
sequentially with another convenience sample of ten
mental health researchers employed in the authors’ uni-
versity departments with feedback used to improve
comprehensibility. A penultimate version entered onto
Survey Monkey [11] was tested for functionality by this
same group of researchers. The final questionnaire
(available on request) included an introduction, and
open and closed questions in three sections. The intro-
duction explained the purpose of the survey and defined
‘gatekeeping’ as allowing or denying a person’s access to
a potential research participant. Sections one and two
comprised the same list of 29 factors influencing re-
searcher access to participants (see Table 1). These fac-
tors related to context, study design, intervention, study
marketing and recruitment strategies. In section one,
participants were asked to indicate whether they had
ever encountered the identified factor while recruiting to
trials and, if so, how often (selecting from ‘never’, ‘occa-
sionally’, ‘commonly’ or ‘almost always’). In section two,
they were asked to rate the impact of each of these fac-
tors on access to potential trial participants by selecting
from ‘positive’, ‘neutral’, ‘negative’ or ‘don’t know’. Re-
spondents were required to make a response to each item
to continue questionnaire completion. Open questions at
the end of each section invited participants to expand on
responses and provide further information about other
factors which, in their experience, influenced recruit-
ment. Section three sought demographic data, but no
identifying information; completion was anonymous.
Study sample and recruitment
The sample comprised clinical studies officers (CSOs)
employed by the MHRN. The MHRN is one of six
topic-specific networks established in 2003 as part of the
National Institute of Health Research (NIHR), to facili-
tate research within the NHS. CSOs at each of eight
locality-based MHRN hubs support and conduct recruit-
ment into publicly and privately funded trials at NHS
Trusts within the hub’s geographically defined area.
While the specific roles and activities of CSOs may differdependent on study or site, in general CSOs are charged
with working collaboratively with clinicians to identify
people who are potentially eligible for trial participation.
Once access to potential participants is achieved CSOs
verify eligibility and undertake consent and study assess-
ment procedures. CSOs are thus well positioned to de-
scribe factors influencing access to participants.
After securing approval of the MHRN Operational
Managers Committee in January 2013, the manager of
each hub was emailed a study synopsis, participant infor-
mation sheet and a link to the online survey. Managers
were asked to forward the email and attachments to all
CSOs employed by the hub. Managers were sent re-
minder emails for distribution to CSOs two and four
weeks after initial contact. The survey link was closed at
the end of February 2013.
Analysis
Data were downloaded from Survey Monkey [12] to
SPSS version 20 [13] for analysis. Descriptive statistics
were used to profile participants and quantify responses
regarding experience of influences on recruitment and
perceptions of impact. Frequency data were tabulated
for categorical variables and means (M) and standard de-
viations (SD) calculated for continuous data. Free text
responses were entered onto Microsoft Word and sub-
ject to thematic analysis using the framework approach
[14] which supported examination of responses relevant
to research objectives and matters arising in respon-
dents’ comments. The first step in the qualitative ana-
lysis was to populate an initial frame comprising cells
representing ‘research objective by participant’ with data
from open questions, with multiple allocations possible.
New cells were created as required to accommodate
data. Once all data were allocated to cells, constant com-
parison and analytic questioning were employed to dis-
cern patterns and exceptions in the data. The frame was
iteratively developed to support exploration of data-based
questions generated as analysis progressed (for example,
to examine the ways ‘culture’ impacted recruitment) and
relationships between the themes. Finally quantitative and
qualitative findings were triangulated to construct the nar-
rative account presented below, which includes verbatim
quotations in “italics”. Analysis was supported throughout
by individual and team reflexivity as developing findings
were subject to intellectual and critical scrutiny [15]. This
scrutiny was underpinned by a pragmatic commitment to
developing findings which could be usefully applied to real
world problems.
Results
Participants
Data were provided by 98 CSOs, (57.6% of the 170 CSOs
employed in all MHRN hubs at the time of dissemination).
Table 1 Prevalence of experience and reported impact of different factors on access to potential participants as reported
by 98 CSOs
A. Has participant
experience of factor?
B. Participants assessment
of the influence of factor
on access to participants
Valid responses = 98
(unless stated)
Enhances
access
Makes no
difference
Inhibits
access
N (%) N (%) N (%) N (%)
Site management position re. trial
1 Gatekeepers refer to the NHS commitment to patient participation in research 41 (41.8) 68 (69.4) 28 (28.6) 2 (2.0)
2 Gatekeepers have protected time to undertake research activity 55 (56.1) 81 (82.7) 8 (8.2) 9 (9.2)
3 Service management proactively endorse the trial and promote referral to
the study
77 (78.6) 93 (94.9) 4 (4.1) 1 (1.0)
4 Managers instruct gatekeepers to refer potential participants 76 (77.6) 83 (84.7) 9 (9.2) 6 (6.1)
5 An identified member of the gatekeeping team is responsible for
facilitating referral
76 (77.6) 80 (81.6) 15 (15.3) 3 (3.1)
Trial design
6 Concurrent recruitment to multiple trials at research site 89/97 (90.8) 11 (11.3) 24 (24.7) 62 (63.9)
7 Trial design is non-simple 78/97 (79.6) 0 (0) 26 (26.8) 71 (73.2)
8 Gatekeepers are masked to treatment allocation 88/97 (89.8) 5 (5.2) 68 (70.1) 24 (24.7)
Site characteristics
9 Site is undergoing substantial change such as reconfiguration or restructuring 92 (93.9) 0 (0) 3 (3.1) 95 (96.9)
Relationship between recruitment and clinic procedures
10 Trial participation requires ongoing involvement of the gatekeeper
(e.g. enabling attendance at an intervention/completing outcome measures)
84 (85.7) 12 (12.2) 10 (10.2) 76 (77.6)
11 Referral to the trial requires gatekeepers to complete questionnaires or an
interview about themselves
45 (45.9) 3 (3.1) 17 (17.3) 78 (79.6)
12 Assessment of eligibility is integrated with routine clinical processes
(e.g. case review)
68 (69.4) 90 (91.8) 6 (6.1) 2 (2.0)
13 Referral requires gatekeepers to complete questionnaires or an interview about
trial participants
80 (81.6) 6 (6.1) 12 (12.2) 80 (81.6)
Characteristics of the trial intervention
14 The trial intervention is only accessible through referral to the trial 95 (96.9) 52 (53.1) 25 (25.5) 21 (21.4)
15 Gatekeepers hold views about the effectiveness and/or appropriateness of
the trial intervention (gatekeeper would not accept that equipoise exists)
93/97 (94.9) 7 (7.2) 6 (6.2) 84 (86.6)
Trial marketing
16 Trial investigators have a structured approach to promoting the trial
to gatekeepers
81 (82.7) 76 (77.6) 17 (17.3) 5 (5.1)
17 A senior member (e.g. principal investigator) of the research team meets with
gatekeepers to promote the trial
74 (75.5) 89 (90.8) 8 (8.2) 1 (1.0)
18 Gatekeepers receive structured updates (e.g. regular newsletters/formal feedback
at meetings) about recruitment progress
90 (91.8) 82 (83.7) 15 (15.3) 1 (1.0)
19 The trial is marketed directly to the target population (with a view to potential
participants seeking referral)
90 (91.8) 87 (88.8) 10 (10.2) 1 (1.0)
Service user involvement
20 Members of the target population (those potentially affected by trial outcomes)
promote referral to the trial, with gatekeepers
39/97 (39.8) 87 (89.7) 10 (10.3) 0 (0)
21 Gatekeepers are advised that the target population has been involved in the trial
design and/or implementation
79 (80.6) 69 (70.4) 28 (28.6) 0 (0)
Clinician attitudes
22 Researchers share the professional background of the gatekeeper 78 (79.6) 58 (59.2) 39 (39.8) 1 (1.0)
23 Gatekeepers express a personal interest in research 93 (94.9) 94 (95.9) 2 (2.0) 2 (2.0)
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Table 1 Prevalence of experience and reported impact of different factors on access to potential participants as reported
by 98 CSOs (Continued)
24 Gatekeepers base referral on criteria other than those specified in the trial protocol
(i.e. they make referrals on the basis of their opinion about suitability)
85/94 (86.7) 11 (11.7) 12 (12.8) 72 (76.6)
25 Gatekeepers believe trial participation will negatively affect their relationship with
potential participants
76 (77.6) 1 (1.0) 5 (5.1) 92 (93.9)
Incentives/motivational interventions
26 Incentives (e.g. chocolates/prize draw) are provided to gatekeepers for the referral
of potential participants
54 (55.1) 70 (71.4) 26 (26.5) 2 (2.0)
27 Researchers encourage competition between study sites in relation to recruitment 86 (87.8) 48 (49.0) 47 (48.0) 3 (3.1)
28 Researchers are set specific recruitment targets which are monitored by their
management
96 (98.0) 54 (55.1) 40 (40.8) 4 (4.1)
29 Site recruitment targets (number of participants and/or time frames) are agreed
with gatekeepers
75 (76.5) 57 (58.2) 37 (37.8) 4 (4.1)
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are the full 98 respondents). Demographic data presented
in Table 2, show that respondents were aged between 23
and 58 years (M= 35.3, SD = 9.4). They were predomin-
ately female (80, 81.6%) and White British (75, 76.7%).
Ninety (91.8%) were tertiary educated with 43 (43.9%) hav-
ing Masters (39; 39.8%) or PhD degrees (4; 4.1%). Partici-
pants reported qualifications in nursing (24; 24.5%),
psychology (31; 31.6%), allied health (11; 11.2%), and phys-
ical sciences (4; 4.1%), with several reporting multiple
professional and/or academic qualifications. Experience
recruiting to trials varied widely from ‘just started’ to
20 years (M= 4.3 years, SD = 4.3). Participants had re-
cruited to an average of six trials (SD = 4.7) from nine
(SD = 9.1) sites, often concurrently recruiting from mul-
tiple populations and settings. Nearly all (87; 88.8%)
had recruited from community mental health services, a
third from residential services (33; 33.7) and almost one
quarter (22; 22.4%) from forensic or secure settings.
In combination, quantitative and free-text data pro-
vided insight to the complexities of recruiting to trials in
NHS mental health settings. Responses to sections one
and two of the questionnaire are summarised in Table 1.
As shown, responses indicated that diverse factors were
influencing recruitment in NHS mental health services.
Respondents generally agreed about whether particular
factors promoted or hindered access to potential partici-
pants. As shown in Table 3 most factors thought to im-
pact positively, and some of those thought to impact
negatively on access to potential participants, were com-
monly experienced by CSOs.
Free-text responses provided by 86 respondents (87.8%)
expanded on and qualified responses, ‘explaining’ findings
and describing additional influences on recruitment. Dif-
ferentiating recruitment in mental health from other ser-
vices, CSOs also wrote of contextual variability within the
sector, identifying cultural, structural, organisational, trial,
setting and interpersonal factors as influencing access topotential participants. They emphasised the need for stra-
tegic and tactical flexibility if access is to be optimised.
Culture and gatekeeping
The broad consensus amongst respondents (94, 95.9%)
was that recruitment potential was optimised when cli-
nicians with a personal interest in research (item 23)
were working within research-friendly cultures. How-
ever, such circumstances were described as the exception
rather than the rule. Endorsement of the NHS commit-
ment to service user participation in research (item 1),
described as enhancing access, was experienced by fewer
than half (41, 41.8%) of participants. Clinicians were
often described as “too busy” to undertake recruitment
(and other research) activities. CSOs observed that re-
search was considered “extra work” rather than a core
responsibility. Hence, gatekeepers often “forgot to ask”
potential participants about studies.
Gatekeepers are busy with long lists of responsibilities;
research comes way down that list. The lack of a
research culture within the NHS is the biggest barrier.
If staff don't see research as an opportunity or relevant
or are intimidated by research, they won't promote it.
It's not about specific staff; it's about the way a team,
the service and the organisation perceive research.
More than three-quarters of CSOs (72/94, 76.6%) re-
ported that gatekeepers applying non-study criteria to
referral had a detrimental impact on referral into trials
(item 24). Criteria reported to be used by clinicians in-
cluded the likelihood of the service user accepting the
invitation, the perceived benefit and the predicted im-
pact on their clinical relationship. Many CSOs described
gatekeepers as paternalistic and over-protective of ser-
vice users, observing that service users’ autonomy was
undermined when referrals were based on “opinions
about suitability or the work associated with referral”.
Table 2 Demographic details and research experience of
98 CSOs
Variable Response N (%)
Gender Male 14 (14.3)
Female 80 (80.6)
Missing 4 (4.1)
Age Years (Mean, SD) 35.3 (9.4)
Ethnicity White British/White Other 81 (82.7)
Asian/Asian British 10 (10.2)
Black/Black British African 1 (1.0)
Black/Black British Caribbean 1 (1.0)
Other 1 (1.0)
Missing 4 (4.1)
Highest academic
qualification
Diploma 5 (5.1)
Bachelor’s degree 42 (42.8)
Masters degree 39 (39.8)
PhD 4 (4.1)
Missing 8 (8.2)
Professional qualifications Psychology 31 (31.6)
Nursing 24 (24.5)
Allied health 11 (11.2)
Physical sciences 4 (4.1)
From which populations
have you recruited
to RCTs?
Children (aged <13) 33 (33.7)
Adolescents (aged 13-18) 50 (51.0)
Adults (aged 18-65) 87 (88.8)
Older adults (aged >65) 49 (50.0)
Severe mental illness 75 (76.5)
Eating disorders 25 (25.5)
Common mental
health problems
67 (68.4)
Drug & alcohol
misuse problems
54 (55.1)
Gambling problems 4 (4.1)
From which settings
have you recruited
to RCTs?
Primary care 37 (37.8)
Community mental
health services
87 (88.8)
Inpatient units 59 (60.2)
Residential services 33 (33.7)
Secure/forensic services 22 (22.4)
Years of experience in
research
Mean (SD) 4.3 (4.3)
Years of experience
recruiting to RCTs
Mean (SD) 3.4 (3.4)
Number of RCTs
recruited to
Mean (SD) 5.8 (4.7)
Number of sites
recruited from
Mean (SD) 9.1 (9.1)
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vice user advocacy roles, respondents argued for service
users’ rights to make decisions “for themselves”.
Just as they should be involved in decisions about their
care, service users should have a choice about
research.
Perceived clinician negativity and ambivalence were
linked to structural and organisational issues. CSOs
wrote that clinicians were distanced from research and
that research-related activity often went unrewarded in
services. They linked this with disjunctions between es-
poused NHS commitment to research, research and de-
velopment (R&D) departments responsible for oversight
of research within Trusts and the clinical services from
which they attempted to recruit. Consensus was that
proactive and pragmatic R&D departments and/or ser-
vice managers, and consistency of research message
within organisations (items 3 [93, 94.9%] and 4 [83,
84.7%]), could enhance recruitment potential.
Unless senior managers endorse research, the 'it’s not
for us' attitude prevails and it is an uphill struggle to
get PIs [Principal Investigators] and clinicians
interested in studies.
CSOs wrote that the apparent failure to translate fi-
nancial incentives paid to Trusts for ‘accrual’ of research
participants into benefits for clinical teams reinforced
clinician scepticism.
What incentives do clinical teams get from their
Trust (rather than the odd packet of chocolate biscuits
from me)?
Within such circumstances, CSOs appreciated gate-
keepers’ perception of research as burdensome, rather
than as a resource (i.e., funding source, enabling access
to an intervention, source of practice-relevant know-
ledge). This already problematic situation was com-
pounded, according to respondents, by the restructuring
of services (item 9) which was a factor encountered by
most respondents (95, 96.9%) of whom almost all felt it
inhibited access (92, 93.9%). The negative impact on re-
cruitment was attributed to demoralisation of clinicians
who experienced job insecurity and lacked the motiv-
ation and cognitive resources needed to undertake re-
search activity.
Study team, trial design and gatekeeping
Data indicated that attention to the impact upon clini-
cians of study design and the procedures for referral into
a trial could strongly influence access. The activities of
Table 3 Distribution of factors influencing recruitment by reported prevalence and impact
Very commonly reported (80% +) Reported by majority (50-79%) Reported by minority (<50%)
Strong consensus (>80%) that factor
enhances access to potential participants
23. Gatekeepers express interest in research 17. A senior member of the research team meets
gatekeepers to promote the trial.
20. Members of the target population (those
potentially affected by trial outcomes) promote
referral to the trial with gatekeepers.
18. Gatekeepers receive structured updates
about recruitment progress
4. Managers instruct gatekeepers to refer participants.
19. The trial is marketed directly to the target
population
5. An identified member of the gatekeeping team is
responsible for facilitating referral.
3. Site management proactively endorses trial referral.
12. Assessment of eligibility is integrated with routine
clinical practice.
2. Gatekeepers have protected time for research.
Majority (50-79%) felt that factor
enhances access to potential participants
14. The intervention is only accessible through
the trial.
29. Site recruitment targets (number of participants
and/or time frames) are agreed with gatekeepers.
1. Gatekeepers refer to the NHS commitment
to patient participation in research.
28. Researchers set recruitment targets. 22. Researchers share the professional background
of the gatekeeper.
16. Trial investigators have a structured
approach to promoting the trial.
26. Incentives (e.g. chocolates/prize draw) are
provided to gatekeepers for the referral of potential
participants.
21. Gatekeepers are advised that the target
population has been involved in trial design
Majority (>50%) reported factor
made no difference
27. Researchers encourage competition
between study sites in relation to recruitment
8. Gatekeepers are masked to treatment
allocation
Majority (50-79%) felt that factor
inhibits access to potential participants
6. Concurrent recruitment to multiple trials is
taking place from individual sites.
11. Referral to the trial requires gatekeepers
to complete questionnaires or an interview
about themselves.
24. Gatekeepers base referral on criteria other
than those specified in the trial protocol.
15. Gatekeepers hold views about the
effectiveness/appropriateness of the intervention.
7. Trial design is non-simple.Strong consensus (>80%) that factor
inhibits access to potential participants
9. Site is undergoing substantial organisational
restructuring/change.
25. Gatekeepers believe trial participation will
negatively affect their relationship with potential
participants.
10. Trial participation requires ongoing
involvement of the gatekeeper.
13. Referral requires gatekeepers to complete
questionnaires or an interview about service users.
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its promotion by investigators, feedback to clinicians on
recruitment), and publicised service user involvement in
the research were also considered influential. Fundamen-
tally, however, CSOs argued strongly that rigorously
conducted feasibility studies which realistically assessed
recruitment potential were crucial to success of a trial.
Such studies would move beyond numbers of potential
participants enrolled at a service to examination of stake-
holder interest in research and capacity to support recruit-
ment; service stability and culture should be examined.
CSOs urged research teams to engage early in the plan-
ning of a study with the MHRN, clinical teams and service
user representatives.
Ask individuals who regularly work with studies and
with teams about potential pitfalls or strategic
knowledge at the development stage - by the time the
study is approved it is often too late to do anything
about it.
The majority of CSOs (76, 77.6%) proposed that such
engagement would inform a contextually relevant, struc-
tured approach to recruitment (item 16).
In relation to study design, most CSOs thought non-
simple (i.e., complex) trial designs impeded recruitment
(item 7) (71/97, 73.2%). Some aspects of trial designs
were described as difficult to communicate and gate-
keepers were seen as less likely to refer when they did
not understand exactly what would happen to potential
participants during a study.
Integrity of the study, congruence of the research
question with service philosophy and trial intervention
with local practice were commonly described as enhan-
cing recruitment.
Few care co-ordinators are interested in telling
patients about pharmaceutical trials, possibly because
they don’t see prescribing medications as their role.
Asserting that gatekeepers refer service users to stud-
ies they consider worthwhile and relevant, CSOs ob-
served that involvement of members of the target
population in study design (item 20; 87/97, 89.7%) and
promotion (item 21; 69, 70.4%), and site visits by senior
investigators (item 17; 89, 90.8%) each enhanced recruit-
ment by building credibility amongst clinicians. Several
CSOs reported finding recruitment easier when trial par-
ticipation facilitated access to a desired intervention
and/or could be viewed as part of the treatment package
provided by the service. Conversely, recruitment was hin-
dered when participation made accessing a readily avail-
able treatment more burdensome, or clinicians held
strong views about the intervention being tested (item 15)(84, 86.6%). Masking gatekeeping clinicians to treatment
allocation (item 8), however, was regarded by the majority
(68, 70.1%) as having little impact on recruitment.
The more work involved, the less likely they are to help
with recruitment.
Perceived or actual demands of study activities on
gatekeepers and participants were described as impact-
ing on recruitment. Whereas integrating assessment of
eligibility with routine clinical processes (item 12) was
viewed as enhancing recruitment by the vast majority
(90, 91.8%) of CSOs, gatekeepers were described as less
likely to refer when they were required to complete
questionnaires about their own practice (item 11; 78,
79.6%) or potential participants (item 13; 80, 81.6%) or if
participation required them to provide ongoing clinical
support (item 10; 76, 77.6%). However, CSOs considered
clinician support crucial to gathering needed data and
noted that information gathered was better quality when
clinicians completed assessment forms. With protection
of potential participants high on clinicians’ agendas, re-
cruitment potential was described as compromised when
participation involved complex and multiple assess-
ments. Conversely, gatekeepers were considered more
likely to refer when trial interventions could be carried
out in a manner consistent with routine practice, mean-
ing minimal inconvenience to participants and fewer de-
mands upon the time of clinical staff involved.
CSOs regarded active involvement of a research assist-
ant (RA) employed by the study team as critical to re-
cruitment success. Noting that CSOs could be required
to be aware of as many as 100 trials while actively
recruiting to many (number not specified) at a given
time, respondents suggested that the study RA could
plan/coordinate promotion and recruitment activities,
ensuring that CSO energies were invested appropriately.
Communication and study materials
Simple, attractive study materials and easy to understand
practical presentations which engaged clinicians were
considered crucial. Provision of a “really basic summary –
a couple of sentences describing the study, then bullet point
main inclusion/exclusion criteria” was described as
minimising burden and thus the risk of ‘screening out’
inappropriately.
Teams prefer an easy read; they want to know what is
expected, not a mundane presentation that they probably
don't understand but won’t ask questions about. They
prefer to see what they have to do in practice.
The vast majority (82, 83.7%) agreed that keeping cli-
nicians informed about study and recruitment progress
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mechanisms, including newsletters and presentations at
meetings were proposed with ’fit’ with circumstance and
relationship considered important determinants of ap-
proach. They also emphasised the importance of making
study findings available to recruitment sites as they be-
came available. As noted by one respondent, inability to
access study results, perhaps because they are “behind a
‘pay wall’”, served to distance gatekeepers from research,
further discouraging engagement.
Incentives
CSOs expressed divergent opinions regarding the impact
of incentives for participants in recruitment. Concern
was expressed that clinicians who considered incentives
coercive inducement were reluctant to refer. However,
more commonly, CSOs’ reported that financial incen-
tives enhanced referral. The provision of incentives was
described as having an unintended impact as well:
Financial incentives for commercial studies
significantly drives recruitment, preventing referral to
studies without the same incentives.
Provision of incentives to gatekeepers (item 26) was
endorsed as enhancing recruitment by almost three
quarters (70, 71.4%) of respondents.
Never take support for granted and remember that as
researchers you’re guests in the clinical area. Always
show respect to staff, patients and carers. Cakes/
chocolates are appropriate to thank staff for
supporting research at busy times and at festival
times.
Several CSOs suggested going beyond gifts of choc-
olate and cake which were commonly described as being
helpful in encouraging clinicians’ engagement. CSOs
could ‘give back’, they proposed, by providing or facilitat-
ing access to research-related training and investigators
could offer publication involvement to motivate gate-
keeper engagement.
Free text expanded on the divergence of opinion evi-
dent in response to item 6 which assessed the way in
which concurrent recruitment to multiple trials from a
given site could affect recruitment. Recruitment could
be made more difficult if gatekeepers were overwhelmed
by requests for referrals or when CSOs and studies were
in competition for a particular population group. Alter-
natively, some respondents thought that recruitment
could be enhanced when potential participants who were
ineligible for one study - but keen to participate in re-
search - could be referred to another. The increased pres-
ence at a site when CSOs were recruiting concurrently tomultiple studies was also seen as supporting establishment
of collaborative relationships, conducive to recruitment.
Enhancing recruitment: what can be done?
Development of a research receptive culture supporting
a critical mass of supportive gatekeepers was described
as critical to optimising recruitment. This, according to
respondents, would require investment (perhaps using
accrual funding) in training of clinicians and protected
research time.
More work needs to be done to free up time of
gatekeepers for involvement with research and more
education needs to be provided by study teams to
gatekeepers to generate interest.
CSOs proposed that academic departments and indi-
vidual investigators had responsibility for developing the
needed research culture. Noting that gatekeepers often
felt ‘used’ by researchers, they argued that research
would only gain credibility when researchers were seen
to contribute to building capacity within services.
Relationships and recognition
At the interface between researchers and clinicians, rela-
tionship was widely regarded as the key to effective re-
cruitment. CSOs stressed the importance of establishing
good working relationships with gatekeepers including/
especially service administrative staff before recruiting to
a study commenced and maintaining good-will over
time.
If a good link is made from site initiation and
sustained, recruitment outcomes are on target 9/10
times more than if research staff drift.
Relationships facilitative of recruitment were described
as grounded in role clarity, respect for others’ responsi-
bilities and reciprocity. CSOs wrote of the importance of
acknowledging challenges faced by clinicians and their
efforts to support research.
Communicating the right (relevant) information to the
right people, often repeatedly, was seen as critical to en-
suring roles and responsibilities were clear and encour-
aging engagement.
High visibility was commonly described as facilitating
the formation and maintenance of the necessary rela-
tionships. In this regard, CSOs reported that ‘having a
desk’ within a clinical team and regularly attending
meetings enabled development of trust and a sense of
shared responsibility for the success of trials. Some pro-
moted the idea that CSOs should be employed by, and
located within, Trusts so that they ‘really were one of the
team’.
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Many CSOs wrote that “direct access” to potential par-
ticipants and immediacy of contact following referral
would enable timely recruitment. CSOs considered dir-
ect access respectful of potential participants’ autonomy
because gatekeepers were not making decisions on their
behalf. They wrote that enrolment was more likely when
potential participants could “see that research has a
friendly face” and information could be provided with-
out delay. Allowing recruitment in waiting rooms and
establishing databases of service users willing to be ap-
proached about studies were proposed as enabling re-
spectful access.
Discussion
Our cross-sectional survey of CSOs has illuminated the
complexities inherent in the task of recruiting trial par-
ticipants from NHS mental health services. Collectively,
findings confirm and consolidate findings from studies
based in particular trials [3,9,10], pointing to a disjunc-
tion between policy and practice. Despite government
declaring a commitment to making research core busi-
ness of the NHS [11], this was not seen by respondents
in our study to be facilitated at the clinical level. Rather
than being enabled to enact the pledge in the NHS con-
stitution to inform patients of studies in which they may
be eligible to participate [16], the majority of mental
health clinicians charged with gatekeeping access are
struggling to cope with competing demands and unable
to prioritise research. Rather than researchers and clini-
cians being allies sharing a purposeful approach to de-
velopment of evidence, our findings are suggestive of a
culture resistant to research. This is likely grounded in
contextual complexities (including physical and emo-
tional distance between R&D departments and the clin-
ical ‘frontline’, and the burden and demands of clinical
work. The reported resistance may in part be grounded
in the redirection of funding from clinical services to es-
tablish the NIHR to increase research capacity within
services. It may also reflect a lack of fit between services
and clinicians and the approaches taken by the MHRN.
Moreover, given recruitment is essentially a social activ-
ity, with success dependent in part on interpersonal con-
nection between recruiting researchers and clinicians
[5], it may well be that some of the challenges described
reflect personal rather than systemic concerns. The key
message arising from this study, however, is that rap-
prochement between the NHS R&D and clinical service
factions and academia is needed to support clinicians to
participate fully in research activity. Whilst cultural trans-
formation, requiring changes in assumptions and values,
is complex, our findings suggest that attention to practical
matters can support this and highlight issues requiring
careful consideration. Before considering these we notestudy limitations which must be borne in mind when
assessing the strength of our evidence.
The nature of the study (cross sectional) and its appli-
cation (construction, sampling and response rate) mean
that we cannot know how representative the picture
constructed from our data is and cannot make any
causal assertions. Our study examined only one perspec-
tive of a complex phenomena (i.e. gatekeepers did not
have a ‘right of reply’) and findings are necessarily con-
strained chronologically and geographically. They are in-
herently shaped by the characteristics and perspectives
of participant CSOs. It is entirely possible that other
CSOs - perhaps working on different trials - or another
sample (perhaps of researchers based in study teams)
might have different experiences and views which may
have challenged or enriched our findings. NHS sites not
covered by the MHRN differ in ways which substantively
affect recruitment to trials. Moreover, as with any quali-
tative analysis, our representation of respondents’ views
expressed in free-text is vulnerable to claims of bias; we
acknowledge that others may have made alternate inter-
pretations. Confidence in our findings is strengthened,
however, by the breadth and depth of experience of the
nearly 60% of eligible CSOs who responded and the
wealth of contextualizing data provided. Triangulating of
quantitative and qualitative responses has enabled devel-
opment of a credible account of recruitment challenges
and opportunities giving rise to recommendations below.
Reciprocity, relevance, respect and realistic feasibility
studies are fundamental to ensuring that recruitment to
trials is to be efficient and clinician-related selection bias
is minimized. Rather than feeling ‘put upon’ by disinter-
ested researchers, gatekeepers should be involved in the
research process from the beginning and have their con-
tributions valued. It behoves researchers, CSOs and the
MHRN to work actively to support clinician and service
engagement and minimise the burden of research activ-
ity. In relation to relevance, the onus is on investigators
and NHS leaders to engage collaboratively with clini-
cians to develop research questions and design studies
which have face validity and will garner support. Re-
sources are critical. Because the absence of dedicated re-
sources (such as clinical time) or return on investment
(such as allocation of accrual funding to team training)
not only constrains the capacity of clinicians to under-
take research activity but undermines belief in policy
and sense that their roles are respected, research re-
sources must be seen to make a difference. At a practical
level, respect and reciprocity can be promoted by effect-
ive communication. Ensuring that the right information
reaches the right people in a timely manner, and that cli-
nicians are provided with progress reports and study
findings, is essential. Offers of publication involvement,
though potentially encouraging activity, should be made
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mixed messages around incentives mean that these
should carefully be considered on a case-by-case basis.
While we set out to explore recruitment to trials in
mental health, we note that the recommendations
grounded in our data could be seen as generic in that
they could apply across health care domains. Determin-
ing which factors, if any, influencing recruitment are pe-
culiar to ‘mental health’ would require a comparative
approach which our study did not have, but which we
would encourage other investigators to adopt. However,
the elusiveness of clinical gains amongst many mental
health service users, the fragility of these gains given the
high rates of relapse and the reality that when gains are
achieved they often require treatment over the long
term, may be one key influence. It is possible that this
generates a conservative and cautious approach to gate-
keeping amongst mental health workers who when in-
vited to judge the potential positive and negative
consequences of participation may see the scales tipped
to often towards the negative.Conclusions
Further research is needed to explicate the complex rela-
tionships between researchers and clinicians to support
development of the necessary alliances. It seems particu-
larly important that clinicians’ voices are heard. Ultim-
ately, there are no simple solutions. If Cochrane's goal of
equitable access to interventions shown to be effective
in properly designed evaluations is to be achieved, the
cultural foundation upon which gatekeepers scaffold evi-
dence construction must be robust.
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